In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor.

Zhou, Jianbiao; Khng, Jiaying; Jasinghe, Viraj J; Bi, Chonglei; Neo, Chiew Hoon Serene; Pan, Mengfei; Poon, Lai Fong; Xie, Zhigang; Yu, Hanry; Yeoh, Allen Eng-Juh; Lu, Yi; Glaser, Keith B; Albert, Daniel H; Davidsen, Steven K; Chen, Chien-Shing

Zhou, Jianbiao; Khng, Jiaying; Jasinghe, Viraj J; Bi, Chonglei; Neo, Chiew Hoon Serene; Pan, Mengfei; Poon, Lai Fong; Xie, Zhigang; Yu, Hanry; Yeoh, Allen Eng-Juh; Lu, Yi; Glaser, Keith B; Albert, Daniel H; Davidsen, Steven K; Chen, Chien-Shing.

Afiliação

Zhou J; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Leuk Res ; 32(7): 1091-100, 2008 Jul.

Article em En | MEDLINE | ID: mdl-18160102

Assuntos

Antineoplásicos/uso terapêutico; Indazóis/uso terapêutico; Leucemia Mieloide Aguda/tratamento farmacológico; Compostos de Fenilureia/uso terapêutico; Inibidores de Proteínas Quinases/uso terapêutico; Tirosina Quinase 3 Semelhante a fms/metabolismo; Transplante de Medula Óssea; Células HL-60; Humanos; Leucemia Mieloide Aguda/metabolismo; Receptores Proteína Tirosina Quinases/antagonistas & inibidores; Transplante Heterólogo

Buscar no Google

Imprimir

XML

PubMed Links

Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Leucemia Mieloide Aguda / Inibidores de Proteínas Quinases / Tirosina Quinase 3 Semelhante a fms / Indazóis / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2008 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links